1. Home
  2. CTMX vs USEG Comparison

CTMX vs USEG Comparison

Compare CTMX & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.25

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$0.93

Market Cap

39.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
USEG
Founded
2008
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
39.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CTMX
USEG
Price
$4.25
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$6.50
$3.50
AVG Volume (30 Days)
2.8M
404.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
50.22
N/A
EPS
0.24
N/A
Revenue
$113,631,000.00
$9,484,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$57.52
P/E Ratio
$17.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.92
52 Week High
$4.62
$6.40

Technical Indicators

Market Signals
Indicator
CTMX
USEG
Relative Strength Index (RSI) 56.24 42.18
Support Level $4.07 $0.93
Resistance Level $4.48 $1.03
Average True Range (ATR) 0.26 0.06
MACD 0.00 0.00
Stochastic Oscillator 65.60 10.87

Price Performance

Historical Comparison
CTMX
USEG

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

Share on Social Networks: